Stock A331920 CELEMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Celemics, Inc.

Equities

A331920

KR7331920009

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 09/05/2024 am IST 		5-day change 1st Jan Change
3,855 KRW +0.13% Intraday chart for Celemics, Inc. +0.92% -8.87%
2022 Celemics, Inc.(KOSDAQ:A331920) dropped from S&P Global BMI Index CI
2021 Celemics, Inc.(KOSDAQ:A331920) added to S&P Global BMI Index CI

Business Summary

Celemics Inc is a Korea-based company mainly engaged in manufacturing products related to life science medicine. The Company mainly develops and sells target capture kit products. In addition, the Company is engaged in immune repertoire analysis solutions and next-generation sequencing solutions. The Company sells its products in domestic and overseas markets.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Life Science and Medicine Product
49.4 %
3,532 40.5 % 3,251 49.4 % -7.97%
Analysis Services
33.3 %
3,063 35.1 % 2,188 33.3 % -28.58%
Life Science and Medicine Merchandise
16.9 %
2,090 23.9 % 1,111 16.9 % -46.82%
Others
0.4 %
44 0.5 % 28 0.4 % -36.83%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
75.5 %
7,046 80.7 % 4,966 75.5 % -29.53%
Others
16.0 %
1,050 12.0 % 1,055 16.0 % +0.41%
Europe
8.5 %
633 7.2 % 557 8.5 % -11.91%

Managers

Managers TitleAgeSince
Hyo-Gi Kim CEO
 Chief Executive Officer - -
Yong-Hoon Lee CEO
 Chief Executive Officer 59 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,164,148 6,837,835 ( 83.75 %) 0 83.75 %

Shareholders

NameEquities%Valuation
Doo-hee Bang
10.12 %
826,499 10.12 % 3 M ₩
Sung-hoon Kwon
3.938 %
321,492 3.938 % 1 M ₩
Ye-won Chung
0.3746 %
30,584 0.3746 % 109 159 ₩
Ji-hoon Lee
0.3629 %
29,631 0.3629 % 105 758 ₩
Sung-yeol Park
0.0867 %
7,077 0.0867 % 25 259 ₩

Holdings

NameEquities%Valuation
IMB DX, INC.
9.83%
 1,375,000 9.83% 36,697,925 $

Company contact information

Celemics, Inc.

19-20th Floor, BYC High City A 131, Gasan digital 1-ro

08506, Seoul

+

http://www.celemics.com
address Celemics, Inc.(A331920)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
CELEMICS, INC. Stock Celemics, Inc.
-8.87% 23.05M
MODERNA, INC. Stock Moderna, Inc.
+23.37% 47.02B
LONZA GROUP AG Stock Lonza Group AG
+49.56% 41.86B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.94% 41.76B
CELLTRION, INC. Stock Celltrion, Inc.
-4.32% 28.8B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.29% 26.05B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.92% 19.15B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+3.20% 12.55B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.67% 11.82B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.23% 12.34B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A331920 Stock
  4. Company Celemics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW